Table 4.
Path-analysis results: direct associations (N = 409)
OUTCOME |
||||||
---|---|---|---|---|---|---|
FNEa |
CESDb |
ADHc |
||||
B | p-value | B | p-value | B | p-value | |
| ||||||
Class 1: Low Stigmas (Ref. group) | ||||||
Class 2: Moderate SU stigma | 4.927 | 0.03 | 7.619 | 0.007 | − 5.086 | 0.30 |
Class 3: Higher HIV and lower SU stigma | 2.511 | 0.01 | 2.175 | 0.24 | − 6.755 | 0.19 |
Class 4: High SU and moderate HIV stigma | 3.293 | 0.001 | 6.354 | < 0.001 | − 9.141 | 0.02 |
Class 5: High HIV and moderate SU stigma | 8.063 | < 0.001 | 6.203 | 0.03 | 2.474 | 0.27 |
FNE | 0.583 | < 0.001 | − 0.248 | 0.03 | ||
CESD | − 0.228 | 0.002 |
B: Unstandardized linear regression coefficient; The model included intersectionality stigma classes, fear of negative evaluation (FNE), depression symptoms (CESD) as predictors of ART adherence (ADH). Model adjusted for covariates, including Age, Income, Marital status, Education, Race, Ethnicity, Drug use.
Fear of Negative Evaluation: Fig. 1, path a;
CESD, Depression symptoms: Fig. 1, path b;
Adherence: Fig. 1, path c